Analysts' Actions: RIMM PFE CAT CSCO NKE

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

Adtran ( ADTN) downgraded at BofA/Merrill to Underperform, Bank of America/Merrill Lynch said. $15 price target. Company is seeing lower domestic spending and facing increased regulatory pressure.

Atwood Oceanics ( ATW) upgraded at Guggenheim from Neutral to Buy, Guggenheim said. $57 price target. Company continues to reinvest free cash flow back into its fleet.

Cameron ( CAM) rated new Buy at Lazard. $69 price target. Copany has good visibility and should deliver solid offshore growth.

Devon Energy ( DVN) rated new Outperform at Credit Suisse. $74 price target. Oil sands projects should help drive near-term growth.

FMC ( FMC) downgraded at BofA/Merrill to Neutral, Bank of America/Merrill Lynch said. Valuation call, based on a $59 price target.

FMC Technologies rated new Buy at Lazard. $60 price target. Company can continue to deliver record subsea results.

Pfizer ( PFE) rated new Outperform at BMO. $30 price target. Company offers stability in uncertain times.

Plains Exploration ( PXP) rated new Neutral at Credit Suisse. Valuation call, based on a $45 price target.

United Technologies ( UTX) downgraded at Oppenheimer to Perform from Outperform, Oppenheimer said. Not sure margin expansion is possible in 2013.

STOCK COMMENTS / EPS CHANGES

Accenture ( ACN) estimates, target upped at Credit Suisse. ACN estimates were boosted through 2015, Credit Suisse said. Company is seeing higher bookings and buying back stock. Neutral rating and new $70 price target.

Accenture target raised at Jefferies. Shares of ACN now seen reaching $66, Jefferies said. Solid quarter and outlook. Hold rating.

Caterpillar ( CAT) estimates trimmed at Citigroup through 2013, Citigroup said. Slower global growth, beyond mining. $92 price target and Neutral rating.

Cepheid ( CPHD) estimates, target cut at Credit Suisse. Shares of CPHD now seen reaching $41, according to Credit Suisse. Estimates also reduced, as growth is decelerating. Outperform rating.

Cisco Systems ( CSCO) estimates increased at Morgan Stanley through 2014, Morgan Stanley said. Checks show that domestic demand continues to improve. Overweight rating and $22 price target.

DuPont ( DD) estimates cut at UBS through 2012, UBS said. Coatings segment earnings now treated as discontinued operations. Neutral rating and $55 price target.

Dell ( DELL) estimates, target cut at Goldman. DELL estimates were reduced through 2014, Goldman Sachs said. Company is leveraged to lower PC demand. Sell rating and new $9 price target.

Discover Financial Services ( DFS) numbers raised at Citigroup. Shares of DFS now seen reaching $43, Citigroup said. Estimates also increased on strong Q3. Neutral rating.

Discover estimates, target boosted at Morgan Stanley. Shares of DFS now seen reaching $42, according to Morgan Stanley. Estimates also upped, as the company is realizing a higher net interest margin. Equal-weight rating.

Edwards Lifesciences ( EW) numbers raised at Jefferies. Shares of EW now seen reaching $125, Jefferies said. Estimates also raised on Physician TAVR survey results. Buy rating.

McCormick & Co ( MKC) numbers raised at Jefferies. Shares of MKC now seen reaching $70, Jefferies said. Estimates also raised on lowered guidance creates entry point. Buy rating.

M&T Bank ( MTB) numbers raised at KBW. Shares of MTB now seen reaching $104, according to Keefe, Bruyette & Woods said. Estimates also increased, as the HCBK deal should add to earnings. Market Perform rating.

Micron ( MU) estimates, target lowered at Credit Suisse. Shares of MU now seen reaching $8, according to Credit Suisse. Estimates also cut, given slower PC growth. Outperform rating.

Nike ( NKE) estimates, target reduced at Credit Suisse. Shares of NKE now seen reaching $91, according to Credit Suisse. Estimates also cut, given lower orders in China. Neutral rating.

Nike estimates raised UBS. NKE estimates raised through 2014, UBS said. US strength and GMs drive EPS upside. Buy rating and $106 price target.

Research in Motion ( RIMM) estimates cut at Credit Suisse through 2014, Credit Suisse said. Company will likely continue to report hardware losses. Neutral rating and $7 price target.

Research In Motion estimates raised at Citigroup through 2014, Citigroup said. Not as bad as feared, but still an EPS loss. $5 price target and Sell rating.

Research in Motion numbers increased at BMO. RIMM estimates were raised through 2014, BMO Capital said. Company is selling more units and realizing higher prices. Market Perform rating and new $8 price target.

Urban Outfitters ( URBN) target raised at BMO. Shares of URBN now seen reaching $45, according to BMO Capital. Visibility has improved following the company's investor meeting. Outperform rating.

>To submit a news tip, email: tips@thestreet.com.

READERS ALSO LIKE:


Follow TheStreet on Twitter and become a fan on Facebook.

This article was written by a staff member of TheStreet.

More from Stocks

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

3 Great Stock Market Sectors Millennials Should Invest In

3 Great Stock Market Sectors Millennials Should Invest In

Why Millennials Are Ditching Stocks for ETFs

Why Millennials Are Ditching Stocks for ETFs

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says